Inês A. Parente , Linda Chiara , Lisa Flammini , Martina Viglioli , Federica Vacondio , Federica Gaiani , Gian Luigi de’Angelis , Marco Pagano Mariano , Silvia La Monica , Elisabetta Barocelli , Simona Bertoni
{"title":"Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions","authors":"Inês A. Parente , Linda Chiara , Lisa Flammini , Martina Viglioli , Federica Vacondio , Federica Gaiani , Gian Luigi de’Angelis , Marco Pagano Mariano , Silvia La Monica , Elisabetta Barocelli , Simona Bertoni","doi":"10.1016/j.ijpharm.2025.126228","DOIUrl":null,"url":null,"abstract":"<div><div>Despite progress in the diagnosis and treatment of inflammatory bowel disease (IBD), its incidence and prevalence continue to rise. The lack of human preclinical models limits the ability to study disease mechanisms and develop effective therapies. Human colonoids provide a physiologically relevant <em>in vitro</em> system that closely mimics the colonic epithelium. In this study, we established an <em>in vitro</em> IBD model using colonoid-derived monolayers and induced inflammation through exposure to TNF-α and IFN-γ. This treatment significantly impaired epithelial barrier integrity and increased the secretion of inflammatory mediators, like IL-8 and CCL20. Although cell metabolic activity was largely preserved, a cytotoxic effect was observed: the increased apoptosis, revealed also by confocal microscopy, and a compromised epithelial renewal, suggested by lower <em>LGR5</em> mRNA transcription, were evidenced. Functionally, inflammatory conditions led to a significant increase in the paracellular transport of atenolol, while the transport of propranolol remained unaffected, highlighting the impact of intestinal inflammation on oral drug absorption and bioavailability. This model provides a robust platform for studying IBD-related epithelial dysfunctions and evaluating potential therapeutic interventions.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"685 ","pages":"Article 126228"},"PeriodicalIF":5.2000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325010658","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Despite progress in the diagnosis and treatment of inflammatory bowel disease (IBD), its incidence and prevalence continue to rise. The lack of human preclinical models limits the ability to study disease mechanisms and develop effective therapies. Human colonoids provide a physiologically relevant in vitro system that closely mimics the colonic epithelium. In this study, we established an in vitro IBD model using colonoid-derived monolayers and induced inflammation through exposure to TNF-α and IFN-γ. This treatment significantly impaired epithelial barrier integrity and increased the secretion of inflammatory mediators, like IL-8 and CCL20. Although cell metabolic activity was largely preserved, a cytotoxic effect was observed: the increased apoptosis, revealed also by confocal microscopy, and a compromised epithelial renewal, suggested by lower LGR5 mRNA transcription, were evidenced. Functionally, inflammatory conditions led to a significant increase in the paracellular transport of atenolol, while the transport of propranolol remained unaffected, highlighting the impact of intestinal inflammation on oral drug absorption and bioavailability. This model provides a robust platform for studying IBD-related epithelial dysfunctions and evaluating potential therapeutic interventions.
期刊介绍:
The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.